Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Staphylococcus aureus mutants selected by BMS-284756.

Antimicrobial agents and chemotherapy - 1 Nov 2001

Discotto L F, Lawrence L E, Denbleyker K L, Barrett J F

Abstract excerpt

BMS-284756, a novel des-fluoro(6)-quinolone, was used to select for in vitro mutants of Staphylococcus aureus ISP794. Step mutants were obtained, and the quinolone resistance-determining regions of four target genes, gyrA, gyrB, grlA, and grlB, were sequenced. The data suggest that DNA gyrase is the primary target for BMS-284756 in S. aureus.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Quinolones
Share to Fluoroquinolones
Share to Indoles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Anti-Infective Agents

Share to Ciprofloxacin

Share to DNA Gyrase

Share to Drug Resistance, Microbial

Share to Staphylococcus aureus

Source

Open in PubMed Open full text

Identifiers

PMID: 11600399
DOI: 10.1128/AAC.45.11.3273-3275.2001
PMCID: PMC90825

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Staphylococcus aureus mutants selected by BMS-284756.PMID 11600399Read ↗

Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.Semantic proximity Read ↗

Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.Semantic proximity Read ↗

Selection and genetic characterization of Streptococcus pneumoniae mutants resistant to the des-F(6) quinolone BMS-284756.Semantic proximity Read ↗

In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates.Semantic proximity Read ↗

DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.Semantic proximity Read ↗

Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.Semantic proximity Read ↗

In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanisms.Semantic proximity Read ↗

Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.Semantic proximity Read ↗

In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci.Semantic proximity Read ↗

Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones.Semantic proximity Read ↗

Quinoline Heterocyclic Clubbed Hydrazone Derivatives as Potential Inhibitors of Mutant S. aureus DNA Gyrase A; An In Silico Drug Discovery Approach -Molecular Docking, MD Simulation, DFT Analysis and ADMET Predictions.Semantic proximity Read ↗

Determination of Disk Diffusion and MIC Quality Control Guidelines for GSK2140944, a Novel Bacterial Type II Topoisomerase Inhibitor Antimicrobial AgentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.